BriaCell Therapeutics Corp.
BCTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001610820
No open-market purchases or sales by BriaCell Therapeutics Corp. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $1.58M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in BriaCell Therapeutics Corp. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +4 vs. Q1 2022
- Shares held
- 2.97M
- −334.6K (−10.1%) vs. Q1 2022
- Total value
- $17.0M
- −$16.5M (−49.2%) vs. Q1 2022
- New holders
- 8
- 6 more added
- Sold out
- 4
- 4 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 19 | $1.58M |
| Q1 2026 | 16 | $1.62M |
| Q4 2025 | 13 | $69.2K |
| Q3 2025 | 13 | $136.5K |
| Q2 2025 | 16 | $181.1K |
| Q1 2025 | 14 | $94.1K |
| Q4 2024 | 26 | $379.1K |
| Q3 2024 | 22 | $538.1K |
| Q2 2024 | 20 | $452.0K |
| Q1 2024 | 20 | $6.38M |
| Q4 2023 | 26 | $14.6M |
| Q3 2023 | 21 | $17.0M |
| Q2 2023 | 21 | $17.9M |
| Q1 2023 | 21 | $19.4M |
| Q4 2022 | 21 | $12.3M |
| Q3 2022 | 22 | $14.3M |
| Q2 2022 | 22 | $17.0M |
| Q1 2022 | 18 | $33.5M |
| Q4 2021 | 20 | $10.9M |
| Q3 2021 | 21 | $4.77M |
| Q2 2021 | 24 | $20.3M |
| Q1 2021 | 10 | $1.45M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding BriaCell Therapeutics Corp.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| K.J. Harrison & Partners Inc | 1,607,027 | $9.19M | 2.48% | +255,245+18.9% | Added |
| Lynwood Capital Management Inc. | 615,000 | $3.55M | 3.96% | −135,000−18.0% | Reduced |
| Wasatch Advisors Inc | 356,498 | $2.06M | 0.01% | +111,807+45.7% | Added |
| Redmond Asset Management, LLC | 137,942 | $796.0K | 0.29% | 00.0% | Unchanged |
| Sabby Management, LLC | 57,589 | $332.0K | 0.62% | +27,627+92.2% | Added |
| Jane Street Group, LLC | 50,284 | $290.0K | 0.00% | +50,284 | New |
| Summit Trail Advisors, LLC | 35,000 | $202.0K | 0.01% | 00.0% | Unchanged |
| Bluefin Capital Management, LLC | 20,696 | $126.0K | 0.02% | +20,696 | New |
| National Bank of Canada | 17,800 | $103.0K | 0.00% | −139,100−88.7% | Reduced |
| Concord Wealth Partners | 17,775 | $103.0K | 0.03% | +1,000+6.0% | Added |
| Apollon Wealth Management, LLC | 15,900 | $92.0K | 0.01% | +2,000+14.4% | Added |
| XTX Topco Ltd | 14,172 | $82.0K | 0.03% | +14,172 | New |
| Virtu Financial LLC | 10,453 | $60.0K | 0.01% | +10,453 | New |
| Tower Research Capital LLC (TRC) | 3,259 | $18.0K | 0.00% | −147−4.3% | Reduced |
| Total Clarity Wealth Management, Inc. | 3,185 | $18.0K | 0.01% | +3,185 | New |
| Morgan Stanley | 2,850 | $16.0K | 0.00% | −17,408−85.9% | Reduced |
| UBS Group AG | 1,672 | $10.0K | 0.00% | +1,368+450.0% | Added |
| Cutler Group LP | 355 | $2.00K | 0.00% | +355 | New |
| Toronto Dominion Bank | 76 | $1.00K | 0.00% | +76 | New |
| Royal Bank of Canada | 174 | $1.00K | 0.00% | +174 | New |
| GHP Investment Advisors, Inc. | 33 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 32 | $0 | 0.00% | 00.0% | Unchanged |
| Leonard Green & Partners, L.P. | 0 | $0 | 0.00% | −500,000−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −25,696−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −15,161−100.0% | Sold out |
| Koshinski Asset Management, Inc. | 0 | $0 | 0.00% | −500−100.0% | Sold out |